Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 2
2014 1
2015 6
2016 5
2017 11
2018 10
2019 11
2020 16
2021 7
2022 7
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.
Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, Zhong J, Rangachari D, Barbie DA, Phat S, Myers DT, Morris R, Kem M, Dubash TD, Kennedy EA, Digumarthy SR, Sequist LV, Hata AN, Maheswaran S, Haber DA, Lawrence MS, Shaw AT, Mino-Kenudson M, Dyson NJ, Drapkin BJ. Farago AF, et al. Among authors: rangachari d. Cancer Discov. 2019 Oct;9(10):1372-1387. doi: 10.1158/2159-8290.CD-19-0582. Epub 2019 Aug 15. Cancer Discov. 2019. PMID: 31416802 Free PMC article. Clinical Trial.
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates.
Sentana-Lledo D, Academia E, Viray H, Rangachari D, Kobayashi SS, VanderLaan PA, Costa DB. Sentana-Lledo D, et al. Among authors: rangachari d. Transl Lung Cancer Res. 2023 Jul 31;12(7):1590-1610. doi: 10.21037/tlcr-23-98. Epub 2023 Jul 5. Transl Lung Cancer Res. 2023. PMID: 37577308 Free PMC article. Review.
Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer.
Viray H, Rangachari D, Costa DB. Viray H, et al. Among authors: rangachari d. N Engl J Med. 2022 May 5;386(18):1769-1770. doi: 10.1056/NEJMc2202305. N Engl J Med. 2022. PMID: 35507494 Free PMC article. No abstract available.
EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
Sheikine Y, Rangachari D, McDonald DC, Huberman MS, Folch ES, VanderLaan PA, Costa DB. Sheikine Y, et al. Among authors: rangachari d. Clin Lung Cancer. 2016 Nov;17(6):483-492. doi: 10.1016/j.cllc.2016.05.016. Epub 2016 Jun 8. Clin Lung Cancer. 2016. PMID: 27381270 Review.
EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors.
Shaffer W, Kobayashi IS, Sentana-Lledo D, Sundararaman S, Lee MD, Rangachari D, VanderLaan PA, Kobayashi SS, Costa DB. Shaffer W, et al. Among authors: rangachari d. Lung Cancer. 2023 Jul;181:107250. doi: 10.1016/j.lungcan.2023.107250. Epub 2023 May 13. Lung Cancer. 2023. PMID: 37196448
76 results